Newsroom

Press Release

NeoGenomics Schedules its Fourth Quarter and Fiscal Year 2017 Earnings Release for February 21, 2018

NeoGenomics Announces Six Clinical Data Presentations to be Made at the American Society of Hematology Meeting

NeoGenomics Joins Thermo Fisher Scientific's Companion Diagnostic Center of Excellence Program with the Launch of Oncomine Dx Target Test

NeoGenomics Europe S.A. Opens its Doors in Rolle, Switzerland Laboratory Hosting Business Leaders, Dignitaries and Local Government Officials

NeoGenomics Announces the Opening of its First International Laboratory near Geneva, Switzerland to Support Clinical Trials

NeoGenomics Reports Revenue of $63.1 Million on 17% Volume Growth and 11% Reduction in Average Cost per Test in the Third Quarter of 2017

NeoGenomics Announces Preliminary Quarter 3 Results, Financial Impacts of Hurricanes and Summary Quarter 4 Guidance

NeoGenomics Schedules its Q3 2017 Earnings Release for October 25, 2017

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients